ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System.

Deemah S Alsuhaibani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.